biocrea acquires CNS pipeline and PDE inhibitor platform from Biotie Therapies Corp. and announces corporate strategy
New entity will be based in Radebeul, Germany
09-Nov-2010 -
biocrea GmbH announced further details about the newly incorporated company and its strategy going forward. biocrea acquires the CNS pipeline and phosphodiesterase enzyme (PDE) inhibitor platform from Biotie Therapies Corp.
The new company will be based in Radebeul, Germany. Dr. Thomas Kronbach, ...
anxiety
collaborations
depressions
+8